Eli Lilly to buy Scorpion Therapeutics’ cancer drug for $2.5 billion
Eli Lilly and Company will acquire Scorpion Therapeutics’ investigational cancer drug, currently being evaluated in first- mid-stage trials to treat breast and solid
Drugs
Health
Medical
Drugs
Medical
Pharma
Johnson & Johnson to acquire Intra-Cellular Therapies Inc., for $14.6 billion
Johnson & Johnson will acquire Intra-Cellular Therapies Inc., a biopharmaceutical company developing drugs for central nervous system disorders, for $14.6 billion, according to
Health
Medical
Research
Easy access to green spaces may solve screen addiction problems in kids
Bharti Jayshankar January 11, 2024: Excessive screen time of children is a growing concern as many studies have correlated cognitive and language skills
Drugs
Pharma
Research
Pfizer’s experimental drug improves survival rates in hard-to-treat bladder cancer
Bharti Jayshankar January 11, 2024: In a breakthrough for bladder cancer treatment, Pfizer’s experimental anti-PD-1 therapy demonstrated superior efficacy compared to the current
Drugs
Medical
Pharma
Biogen Inc., to buy 62m outstanding shares of Sage for $441.7 million
Biogen Inc., plans to buy all outstanding shares totalling 61.17 million of Sage Therapeutics Inc., for $7.22 a share, representing a premium of
Drugs
Health
Pharma
Vertex, China’s Zai to develop, commercialise kidney disease drug
US-based Vertex Pharmaceutical Inc. has signed a licensing pact with China’s Zai Lab Ltd. to develop and commercialise the Boston-headquartered company’s medicine, which
Drugs
Health
Medical
Pfizer’s trial antibody for type of bladder cancer meets main goal
Pizer Inc.’s late-stage trial of an antibody treatment for a certain type of bladder cancer has shown significant improvement in time patients remained
Uncategorized
One in 127 people globally have autism spectrum disorder: Study
About 61.8 million globally, or one in every 127 people, had autism spectrum disorder in 2021, according to new research that expanded on
Health
Medical
Pharma
J&J pauses rollout of heart device in US after ischemic, stroke incidents
ohnson & Johnson paused its rollout of a heart device to treat atrial fibrillation “out of an abundance of caution,” as it probes four
Health
Medical
Research
Sugary drinks linked to millions of diabetes, heart disease cases
HQ Team January 10, 2024: The global health burden of sugary drinks has reached alarming levels, with a new study published in Nature